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Abstract
DNA cytosine methylation is involved in the regulation of gene expression during develop-
ment and its deregulation is often associated with disease. Mammalian genomes are pre-
dominantly methylated at CpG dinucleotides. Unmethylated CpGs are often associated with
active regulatory sequences while methylated CpGs are often linked to transcriptional
silencing. Previous studies on CpG methylation led to the notion that transcription initiation
is more sensitive to CpG methylation than transcriptional elongation. The immunoglobulin
heavy chain (IgH) constant locus comprises multiple inducible constant genes and is
expressed exclusively in B lymphocytes. The developmental B cell stage at which methyla-
tion patterns of the IgH constant genes are established, and the role of CpG methylation in
their expression, are unknown. Here, we find that methylation patterns at most cis-acting
elements of the IgH constant genes are established and maintained independently of B cell
activation or promoter activity. Moreover, one of the promoters, but not the enhancers, is
hypomethylated in sperm and early embryonic cells, and is targeted by different demethyla-
tion pathways, including AID, UNG, and ATM pathways. Combined, the data suggest that,
rather than being prominently involved in the regulation of the IgH constant locus expres-
sion, DNA methylation may primarily contribute to its epigenetic pre-marking.
Author summary
DNA methylation mainly occurs at CpG dinucleotides and strongly influences gene
expression during development. Deregulation of DNA methylation is often associated
with disease. In mammalian genomes, unmethylated CpG dinucleotides are generally
associated with active regulatory sequences, while methylated CpGs are often associated
with silent promoters. The immunoglobulin heavy chain constant locus comprises multi-
ple inducible constant genes and is expressed exclusively in B lymphocytes. We show that
methylation patterns of most of the locus cis-elements, including promoters, enhancers
and insulators, are established and faithfully maintained independently of B cell activation
or transcription initiation. Acquisition of DNA methylation by the constant genes exons
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occurs independently of transcriptional elongation. One late B cell specific promoter is
hypomethylated early in ontogeny. Constant genes promoters recruit different demethyla-
tion pathways that become dispensable for the maintenance of the mark in the B cell line-
age. The data suggest that, rather than playing a prominent role in transcriptional
regulation, DNA methylation may contribute to the epigenetic pre-marking of the IgH
constant locus.
Introduction
DNA methylation is a common epigenetic regulation mechanism in vertebrates and is
involved in gene expression regulation during development and differentiation as well as in
defense of the genome against transposable elements. DNA methylation provides a robust epi-
genetic mechanism for cell fate decisions, cell identity and tissue homeostasis. The importance
of this epigenetic regulation is highlighted by the finding that its absence is lethal and aberrant
DNA cytosine methylation is often associated with disease such as cancer [1].
Mammalian genomes are predominantly methylated at cytosines in the context of CpG
dinucleotide. Mammalian genomes are mostly CpG-poor and these CpG motifs are globally
methylated. However, a minority of CpGs occur in CpG-dense regions called CpG islands
(CGIs) and are generally refractory to DNA methylation. While unmethylated CpG sites and
CGIs are generally associated with active promoters, methylated CpGs (mCpGs) and mCGIs
are closely associated with transcriptionally silent promoters. This pattern is less obvious when
it comes to transcription elongation as mCpGs and mCGIs in gene body did not block elonga-
tion, leading to the notion that it is transcription initiation that is more sensitive to cytosine
methylation [2–4].
B lymphocytes are derived from pluripotent hematopoietic stem cells and develop in fetal
liver during embryonic development, then shift to the bone marrow around birth [5]. B cell
development requires assembly of its antigen receptor loci through V(D)J recombination
which occurs in developing B cells in fetal liver and bone marrow [6, 7]. Further development
leads to migration to peripheral lymphoid organs such as the spleen where, upon antigen
encounter, mature B cells can undergo another recombination process called class switch
recombination (CSR). CSR enables IgM-expressing B cells to switch to the expression of other
antibody classes, specified by different constant genes. Each constant gene is part of a tran-
scription unit where transcription, termed germline (GL) transcription, initiates at an induc-
ible promoter (called I promoter) and terminates downstream of the constant exons [8]. GL
transcription is associated with various induced epigenetic changes (e.g. [9, 10]) and is con-
trolled by different cis-regulatory elements including enhancers and insulators (e.g. [11–14]).
In particular, the 30 regulatory region (30RR), which contains four enhancers located down-
stream of the IgH locus, effects a long-range enhancing activity on the multiple I promoters
[15].
While V(D)J recombination targets all antigen receptor loci in B and T lymphocytes [7],
CSR is strictly B-cell specific and targets exclusively the immunoglobulin heavy chain (IgH)
locus [8]. This highly restricted targeting raises important developmental questions. For
instance, it is still unknown whether all the epigenetic features of the IgH constant locus are
acquired de novo in the B cell lineage and at the right B cell developmental stage, i.e. when GL
transcription occurs, or whether the locus is at least in part epigenetically pre-marked.
Here, we focused on DNA methylation and used bisulphite sequencing to analyze the meth-
ylation profiles of multiple cis-acting elements at the IgH constant locus. We show that the
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methylation patterns of most cis-acting elements are established and faithfully maintained
independently of B cell activation or GL transcription. Moreover, one I promoter, but not
enhancers, was hypomethylated early during ontogeny and recruited different demethylation
pathways.
Results
Induction of GL transcription and CpG demethylation in primary B cells
Splenic B cells can be activated by various extracellular signals (mitogen, cytokines. . .). Each
stimulation condition induces a specific (set of) I promoter(s) and directs CSR to the corre-
sponding constant gene(s) [8]. We checked induction of GL transcription and as expected,
RT-qPCR and FACS revealed high levels of GL transcripts and robust CSR upon appropriate
stimulation (S1 Fig).
To analyze methylation profiles of I promoters, we used bisulphite sequencing. Because this
technique does not discriminate 5-methylcytosine from 5-hydroxymethylcytosine, a fraction
of methylated cytosines may include 5-hydroxymethylcytosines. Conversely, a fraction of
unmethylated cytosines may include 5-carboxylcytosines and 5-formylcytosines. Throughout
this study, we did not quantify the levels of the oxidized methylcytosines.
In order to determine if and how CpG methylation patterns are affected upon induction of
GL transcription, we first compared the methylation state of all CpGs at I promoters and flank-
ing sequences (Fig 1A), in resting and activated splenic B cells. We focused on the promoters’
CpGs to establish the link between DNA methylation and transcription initiation, but we also
analyzed I exons and different constant exons as sites of transcriptional elongation. Analysis of
some CpGs upstream of the promoters, located outside the transcription units and the known
regulatory regions, served as “negative controls” as we anticipated them to be hypermethylated
(S2 Fig and S3 Fig).
Inspection of the data revealed various unexpected aspects of CpG methylation in the IgH
constant locus. In particular: Most CpGs upstream of the promoters were heavily methylated
in resting B cells and remained so after activation (Fig 1B–1E and S3 Fig). Strikingly, some
promoters’ CpGs, notably the unique CpG at Iγ3 (see discussion), three CpGs at Iγ2b, and one
CpG at Iα promoters, were fully unmethylated in resting B cells (Fig 1B and 1E). At the pro-
moters, there was no obvious correlation between promoter activation and CpG demethyla-
tion (Fig 1B–1E), except for the Iγ1 promoter’s unique CpG, which lost all methylation upon
IL4 activation (Fig 1D). The nature of the stimulus did not alter the CpG methylation state of
Iγ2b promoter as a similar pattern was observed following either LPS or TGFβ stimulation,
which both activate this promoter (Fig 1B and 1E). A positive correlation between induction
of GL transcription and CpG demethylation could be seen for specific, mostly proximal, CpGs
at Iγ3, Iγ1, Iγ2b and Iγ2a exons (hereafter Iγ exons). In contrast, the CpGs of Iε and (more
markedly) Iα exons remained hypermethylated (Fig 1B–1E). CpG methylation status of all
constant exons studied (Cγ3, Cγ1, Cγ2b, and Cα) was unchanged upon appropriate activation
(Fig 1B, 1D and 1E). The targeting of CpGs for (de)methylation is highly focused, i.e., there is
no evidence for spreading of this epigenetic mark as best illustrated by the hypomethylated
CpG of Iα promoter (Fig 1E and S3 Fig) (see below).
The demethylated state of Iγ3 and Iγ2b promoters is independent of their
activity
In order to determine whether CpG demethylation occurs as a consequence of B cell activation
or whether it is a direct consequence of GL transcription per se, we investigated CpG
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methylation in genetic contexts where Iγ3 and Iγ2b promoters were silenced in activated B
cells, or constitutively active in resting B cells. In ZILCR mouse line, the chicken β-globin core
insulator was inserted upstream of the 3’RR, resulting in a complete silencing of Iγ3 and Iγ2b
promoters upon LPS stimulation (Braikia and Khamlichi, in preparation). In the second
mouse model, the 5’hs1RI CTCF insulator within the Cα constant gene was deleted, leading to
constitutive activity of Iγ3 and Iγ2b promoters in resting B cells [13] (Fig 2A and 2B).
The unmethylated state of Iγ3 and Iγ2b promoters remained essentially unchanged in LPS-
activated ZILCR B cells (Fig 2A), and in unstimulated 5’hs1RI splenic B cells (Fig 2B). In LPS-
Fig 1. DNA methylation patterns at the IgH constant locus in resting and stimulated splenic B cells. (A) Scheme of the mouse IgH constant locus. The CpGs
sequenced map to the regions depicted in orange. These include GL promoters (PIx) and upstream regions, I exons (Ix) and Cγ3, Cγ1, Cγ2b and Cα exons. Note that the
distal CpG at Iγ2b promoter maps right upstream of the distal SMAD3 binding site (see S2 Fig), therefore, there is an uncertainty whether this CpG is truly part of the core
promoter. The arrow indicates transcription start site. For convenience, only one initiation site is shown but GL transcripts initiate at multiple sites. Eμ enhancer acts as an
enhancer and a GL promoter (hence Eμ/PIμ). The 3’RR is also indicated downstream of the locus (not to scale). (B-E) Genomic DNAs were purified from CD43- WT
splenic B cells (d0) and at day 2 (d2) post-stimulation and assayed by bisulphite sequencing. The top panels represent the sequencing results from resting splenic B cells
(d0). The bottom panels represent those from activated splenic B cells (d2): (B) LPS stimulation (which induces Iγ3 and Iγ2b promoters), (C) IFNγ stimulation (induces
Iγ2a promoter), (D) IL4 stimulation (induces Iγ1 and Iε promoters), (E) TGFβ stimulation (induces Iγ2b and Iα promoters). The localization of the sequenced CpGs is
displayed in the upper schemes. The unmethylated and methylated cytosines are represented by open and filled circles, respectively. The percentage of methylation is
indicated underneath the circles for the indicated elements. Note that the panel of Iγ2b region in resting B cells (d0) is the same in (B) and (E). Iγ2a promoter does not
contain any CpG, the most proximal lies at 88 bp upstream of RUNX1 binding site. See S2 Fig and S2 Table for additional information on the localization of, and the
distance between, the sequenced CpGs.
https://doi.org/10.1371/journal.pgen.1007930.g001
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activated ZILCR B cells, the methylation pattern of Iγ3 and Iγ2b exons was comparable to that
seen in WT resting B cells (Fig 1B and Fig 2A). When Iγ3 and Iγ2b promoters were active in
the absence of B cell activation, a lack of methylation was seen at exons Iγ3 and Iγ2b that was
globally similar to that in LPS-activated WT B cells (Fig 1B and Fig 2B).
Taken together, the data from WT and mutant splenic B cells demonstrate that the
unmethylated state of Iγ3 and Iγ2b promoters is locally established prior to B cell activation
and transcription induction, and is maintained independently of B cell activation and pro-
moter activity. Additionally, insulation of the 3’RR does not affect the methylation pattern of
Iγ3 and Iγ2b promoters. In contrast, the relative demethylation of Iγ3 and Iγ2b exons results
from GL transcription and not from B cell activation.
Fig 2. DNA methylation and transcriptional activity of Iγ3 and Iγ2b promoters. (A) The upper scheme indicates
the insertion site of the ectopic CTCF insulator (in red) right upstream of the 3’RR (ZILCR mouse line). The insertion
results in a complete shut-down of Iγ3 and Iγ2b promoters upon LPS stimulation. The panels report the results of
bisulphite sequencing (d2 post-LPS stimulation). (B) The upper scheme indicates the deletion of the endogenous
CTCF insulator within α constant gene (dotted red oval) (5’hs1RI mouse line). The deletion results in a constitutive
activity of Iγ3 and Iγ2b promoters in resting B cells. The panels show the results of bisulphite sequencing on CD43-
sorted splenic B cells (d0).
https://doi.org/10.1371/journal.pgen.1007930.g002
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Methylation patterns of IgH cis-acting elements are established and
maintained independently of B cell activation
Iγ3 and Iγ2b promoters were unmethylated prior to, and following B cell activation, reminis-
cent of Eμ enhancer and the 3’RR [16–19]. This led us to explore the methylation pattern of
other cis-acting elements, with known or suspected regulatory function. We focused on three
CpG-rich clusters at Cδ-Iγ3 intergenic region (3’δ1 to 3’δ3) (Fig 3A). Two clusters (3’δ1 and
3’δ2) flank a region that is highly enriched in transcription factors binding sites and may play a
role in early B cell development [20]; the other, located further downstream, is used as a nega-
tive control. We also examined two DNase I hypersensitive sites within Cγ1-Iγ2b intergenic
region (hereafter 3’γ1E and 5’γ2bE) that bind various transcriptional/architectural factors [21,
Fig 3. DNA methylation patterns of different cis-acting elements of the IgH constant locus in resting and activated splenic B cells. (A) Top. Scheme of the IgH
constant locus depicting the relative position of the mapped elements, in red (3’γ1E) and in green (3’δ1, 3’δ2, 3’δ3, 5’γ2bE and 5’hs1RI) (see text for details). Bottom.
Bisulphite sequencing assays were performed on genomic DNAs from purified WT resting splenic B cells (d0, top panels) and from activated splenic B cells (d2 post-LPS
stimulation, bottom panels). (B) The hypomethylated state of the 3’γ1E is not affected by ectopic insulation of the 3’RR (top panel) or by deletion of the endogenous
5’hs1RI insulator. (C) The hypermethylated state of the 5’γ2bE does not vary upon TGFβ stimulation (compare with LPS stimulation in (A)). The 9 CpGs coincide with
the DNaseI hypersensitive site (see text for details), and are right upstream of the 5 CpGs shown in Figs 1 and 2, which illustrates the hypermethylated state of the region
upstream of Iγ2b (see S2 Fig and S2 Table for the localization of, and the distance between, the sequenced CpGs).
https://doi.org/10.1371/journal.pgen.1007930.g003
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22] and are involved in long-range interactions with multiple regulatory elements of the IgH
locus in early B cells [21]. Additionally, 3’γ1E displays enhancer activity in pro-B cells [22].
Finally, we analyzed the intragenic 5’hs1RI insulator region whose CTCF binding site does not
contain any CpG but is flanked by two clusters of 3 and 11 CpGs [13].
The data showed distinct CpG methylation patterns: 3’γ1E was largely unmethylated, both
in resting and LPS-activated splenic B cells (Fig 3A) and its pattern was unchanged upon insu-
lation of the 3’RR or deletion of 5’hs1RI (Fig 3B). The 3’δ1–3, 5’γ2bE and 5’hs1RI elements
were hypermethylated in resting B cells as well as after LPS activation (Fig 3A). 5’γ2bE CpGs
were also methylated in TGFβ-activated splenic B cells (Fig 3C).
Ontogenic, lineage-, and cell-type specific CpG demethylation of Iγ3, Iγ2b
promoters and 3’γ1E enhancer
The finding that Iγ3 and Iγ2b promoters and 3’γ1E enhancer were essentially unmethylated in
resting splenic B cells led us to investigate when their non-methylated state was established,
and whether this state was B cell-specific. To this end, we analyzed CpG methylation in various
tissues and cell types. As controls, we assayed the Eμ enhancer, known to undergo lymphoid-
specific demethylation and to remain unmethylated throughout B cell development [17, 19],
and 5 CpGs upstream of Iγ2b which were heavily methylated in splenic B cells (Figs 1 and 2).
Indeed, The 5 CpGs upstream of Iγ2b were hypermethylated regardless of the cell type ana-
lyzed (Fig 4A and 4B). In contrast, Eμ was only minimally methylated in CD4+ T cells (10% of
mCpGs), and was fully unmethylated in WT fetal liver B cells and in pro-B cells derived from
the bone marrow of Rag2-deficient mice (Fig 4B). However, Eμ was relatively more methyl-
ated in mature sperm (64%), in serum-grown embryonic stem cells (ESCs) (51%) and in the
tail tissue of Rag2-deficient mice (76%) (Fig 4A). The 5’γ2bE was heavily methylated in all tis-
sues and cell types analyzed except in ESCs where it was relatively less methylated (58%) (Fig
4A and 4B). Interestingly, 3’γ1E underwent a strict B cell-specific demethylation, contrasting
with Eμ enhancer whose demethylation was more pronounced in T cells (Fig 4B). Impor-
tantly, Iγ3 promoter was markedly hypomethylated in sperm (31%) (Fig 4A), whereas Iγ2b
promoter (69%) (Fig 4A) and Iγ1 (100%) and Iα (81%) promoters (S4 Fig) were heavily meth-
ylated. Importantly, Iγ3 promoter and, to lesser extent, Iγ2b promoter underwent further
demethylation in ESCs (8% and 51% respectively) (Fig 4A). In non-B cells, compared to ESCs,
Iγ3 and Iγ2b were more methylated in Rag2-/- tail (40% and 65% respectively) (Fig 4A),
whereas in CD4+ T cells, Iγ3 underwent moderate methylation (31%) while Iγ2b was further
demethylated (25%) (Fig 4B). Remarkably, in the B cell lineage, Iγ2b promoter was more
demethylated than Iγ3 promoter in fetal liver (7% and 35% of mCpGs). Iγ3 promoter became
fully unmethylated in pro-B cells of Rag2-deficient mice (Fig 4B and S5 Fig).
Altogether, the data revealed that, among the cis-acting elements analyzed, Iγ3 promoter
was already hypomethylated in sperm and ESCs, and fully unmethylated in pro-B cells of adult
mice. Iγ2b promoter, Eμ and 3’γ1E enhancers were hypermethylated in sperm but underwent
massive demethylation in fetal liver B cells.
Pathways that influence CpG methylation differentially affect Iγ3 and Iγ2b
promoters
The above data showed that Iγ3 and Iγ2b promoters displayed different dynamic methylation
patterns during embryonic development and cell differentiation, and that in sperm and ESCs,
Iγ3 promoter was hypomethylated compared to Iγ2b. One possibility is that the two promoters
are targeted by different demethylation machineries. In an attempt to identify the demethyla-
tion pathways involved, we assayed for CpG methylation at Iγ3 and Iγ2b promoters in mature
Regulation of DNA methylation at the IgH locus
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sperm and resting splenic B cells of mice with Activation-induced cytidine deaminase (AID),
Uracil DNA glycosylase (UNG), Ataxia telangiectasia mutated kinase (ATM), or the Tumor
suppressor protein p53 deficiency (see discussion).
Strikingly, Iγ3 promoter displayed a hypermethylated pattern in AID-, UNG-, and ATM-
deficient sperm compared to WT control (Fig 5A). In contrast, the methylation pattern of Iγ3
promoter did not significantly change in p53-deficient sperm (Fig 5A). The methylation pat-
tern of Iγ2b promoter was not significantly affected regardless of the genetic deficiency (Fig
5A). For all deficiencies analyzed, the methylation pattern of Iγ3 and Iγ2b promoters was simi-
lar to WT in B cells (Fig 5B).
The data established that in mature sperm, Iγ3 and Iγ2b promoters displayed different
methylation patterns, and that Iγ3 promoter was specifically hypermethylated in AID-, UNG-,
and ATM-deficient sperm. In resting B cells however, the unmethylated profile of both pro-
moters was essentially insensitive to AID, ATM, UNG, or p53 deficiency.
Fig 4. Methylation patterns of IgH cis-acting elements during ontogeny. The top scheme indicates the cis-acting
elements mapped (Eμ/Iμ enhancer/GL promoter; Iγ3 and Iγ2b promoters, and 3’γ1E and 5’γ2bE). The 5
hypermethylated CpGs upstream of Iγ2b promoter (as determined in resting B cells, see Figs 1 and 2) were included as
a “negative” control. For 5’γ2bE, only 3 CpGs (out of the 9 CpGs shown in Fig 3) were analyzed. See also the note on
the distal CpG at Iγ2b promoter in the legend to Fig 1. Bisulphite sequencing maps for the indicated cis-acting
elements were determined. (A) In non-lymphoid cells/tissues: mature sperm (top), ESCs (middle), tail of Rag2-
deficient mice (devoid of any circulating lymphocytes) (bottom). (B) In lymphoid cells: splenic CD4+ T cells (top), fetal
liver B cells (middle), and Rag2-deficient pro-B cells (bottom).
https://doi.org/10.1371/journal.pgen.1007930.g004
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Discussion
Four main conclusions emerge from this study. DNA methylation does not play a significant
role in IgH constant genes expression. Acquisition of DNA methylation by the constant exons
is not mediated by transcriptional elongation. The hypomethylated pattern of the late B cell-
specific Iγ3 promoter was manifest in mature sperm and ESCs already, in contrast to Eμ and
3’γ1E enhancers and other I promoters. Iγ3 and Iγ2b promoters recruited different demethyla-
tion pathways.
Except for Iγ1, B cell activation and induction of GL transcription did not perturb the
methylation patterns of I promoters. Explanations such as the nature of the stimulus or the
number of promoter CpGs cannot explain these patterns. For instance, Iγ1 and Iε promoters
Fig 5. Pathways involved in the demethylation of Iγ3 promoter. (A) The table on the left summarizes the results of bisulphite sequencing of the CpGs analyzed (upper
scheme) in sperm of WT adult males or with the indicated deficiencies. For each genotype, the number of mice, the total number of sequences, of demethylated CpGs
(CpGs), of methylated CpGs (mCpGs), and the percentages of mCpGs (highlighted), are indicated. The histograms on the right show the statistical data for each individual
CpG displayed on the upper scheme. The differences observed between WT and mutant mice were evaluated by unpaired t-test. The difference between means is
significant if p< 0.05 (�), very significant if p< 0.01 (��); ns, not significant. (B) Methylation patterns of Iγ3 and Iγ2b promoters in resting splenic B cells with the
indicated genotypes.
https://doi.org/10.1371/journal.pgen.1007930.g005
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are both induced by IL4 stimulation, but while Iγ1 underwent full demethylation, Iε did not.
On the other hand, both Iγ3 and Iγ1 promoters contain a single CpG, but while Iγ3 was
already unmethylated in resting B cells, Iγ1 became fully unmethylated only after induction. In
this regard, various studies showed that methylation of a single CpG can have important func-
tional or pathological consequences [23–26].
GL transcription at the IgH constant locus is largely controlled by the 3’RR [15], which was
shown to engage in long-range interactions with I promoters through chromatin looping, in a
stimulus-dependent manner [27–30]. Additionally, the 3’RR controls various active histone
modifications at I promoter/exon regions [31]. Our findings strongly suggest that the forma-
tion of IgH loops and the set-up of active histone marks associated with I promoters activation
do neither require nor induce demethylation of I promoters. Significantly, Iγ3 and Iγ2b pro-
moters are the most sensitive to 3’RR mutations (e.g. [11, 12]). Nonetheless, their unmethy-
lated pattern did not change upon insulation of the 3’RR, which fully repressed these
promoters. The 3’RR thus controls Iγ3 and Iγ2b promoters through mechanisms that do not
involve DNA methylation, contrasting in this regard with other Ig enhancers (e.g. [17, 19, 32]).
It remains to be established whether the 3’RR displays a demethylating activity at earlier B cell
developmental stages. Paradoxically, Iγ1, known to be relatively 3’RR-independent (e.g. [11,
12]), was the only I promoter whose demethylation was induced. This may relate to the pres-
ence of specific regulatory elements with demethylating activity such as the putative Iγ1 pro-
moter-associated enhancer [33], and/or the 3’γ1E enhancer. Testing these hypotheses still
awaits appropriate knock-out models.
Induction of GL transcription led to a moderate hypomethylation of essentially the most
proximal CpGs of Iγ exons. This may be due to pausing of RNA pol II that takes place 30–60
nucleotides downstream of the transcription start site(s). Accordingly, high-levels of RNA pol
II p-Ser5 were detected at Iγ3 exon upon LPS stimulation [9], which may protect some CpGs
against methylation. Methylation of Iε and Iα exons, however, was not impacted by stimula-
tion, suggesting that the mechanisms that underlie pausing at I exons may differ.
Seminal studies using transformed cell lines and methylation-sensitive restriction enzymes
found a positive correlation between DNA hypomethylation and constant genes transcription
[34–37]. However, this correlation was not observed in primary B cells [38]. Accordingly, we
found that Cγ3, Cγ1, Cγ2b and Cα exons were already hypermethylated in unstimulated splenic
B cells and remained so after induction of GL transcription, regardless of the nature of the stim-
ulus. This indicates that transcriptional elongation across the chromatin of constant exons does
not bring about any obvious change of their hypermethylated pattern. Interestingly, this hyper-
methylated pattern coincides with transcription-associated deposition of H3K36me3 at Cγ
exons [9]. In genomic imprinting for instance, acquisition of DNA methylation through tran-
scription-associated H3K36me3 has been demonstrated for some imprinting control regions.
In this process, H3K4 methylation, which prevents the action of DNMT3A-DNMT3L de novo
methyl-transferase complex, is first removed from chromatin, this enables transcription-associ-
ated H3K36me3 to recruit DNMT3A-DNMT3L complex that will methylate DNA [39]. This is
clearly not the case for IgH constant exons which are likely methylated through a different
mechanism.
Previous work indicated that H3K36me3 and intragenic DNA methylation contribute to
the silencing of alternative, intragenic promoters [40, 41]. Low levels of antisense switch tran-
scripts have been detected (e.g. [42, 43]), but antisense promoters have not been precisely
defined. Intragenic methylation may contribute to down-regulation of the antisense promoters
and/or other cryptic promoters. An attractive possibility could be that DNA hypermethylation
and H3K36me3 across the constant exons protect these regions from AID attack by favoring
a compacted chromatin structure after nucleosome displacement induced by RNA pol II
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passage. This chromatin-based protection mechanism is physiologically relevant as the con-
stant exons are coding sequences whose reading frame must be preserved if the Ig heavy chain
is to be produced. In this regard, the highly cytosine-rich, non-coding switch sequences, which
are preferentially targeted by AID during CSR are strikingly poor in CpG [44] compared to
constant exons.
Two major waves of DNA methylation reprogramming occur during development, shortly
after fertilization and in primordial germ cells (PGCs). After the massive methylation erasure
in PGCs, de novo DNA methylation is acquired in prenatal prospermatogonia before birth.
The methylation patterns are fully established at birth and are maintained before the cells
enter meiosis [45, 46], and it was shown that sperm cells display the highest global DNA meth-
ylation level [47]. In stark contrast to I promoters, and to Eμ and 3’γ1E enhancers, Iγ3 was
already hypomethylated in mature sperm. Moreover, Iγ3 promoter underwent further
demethylation in serum-grown ESCs despite the fact that ESCs grown in this condition display
high DNA methylation levels [48], comparable to those of mature sperm [47]. These findings
suggest that Iγ3 promoter is hypomethylated in pre-implanted embryo. Upon differentiation
however, Iγ3 promoter moderately acquires DNA methylation and is fully unmethylated only
in B cells of adult mice. Altogether, the above findings strongly suggest that the cis-acting ele-
ments analyzed are targeted by (de)methylating activities in a highly specific manner. The dif-
ferential targeting is also evident from the patterns of Iγ3 and Iγ2b in sperm with AID, UNG,
ATM or p53 deficiency.
The role of AID in DNA demethylation is still controversial (e.g. [45, 46, 49–51]). AID was
implicated both in vitro and in vivo at various stages of mouse embryonic development [47, 52,
53]. Our data show that Iγ3, but not Iγ2b, is hypermethylated in AID-deficient sperm. This
indicates that AID demethylation pathway is involved, and preferentially targets Iγ3 promoter.
Whether it is AID itself, or a cofactor, that is directly implicated is presently unclear. Also, we
do not infer that AID-mediated demethylation occurs in mature sperm. Demethylation may
have occurred in PGCs, and the hypomethylated pattern subsequently maintained during the
establishment of the male germ line. In this regard, low levels of AID expression were detected
in PGCs but not in the germ line [52, 54].
Preferential targeting of Iγ3 promoter was also evident in UNG-deficient sperm. The base
excision repair pathway [54], and in particular UNG which excises uracil from DNA, has been
implicated in DNA demethylation in zygotes and PGCs [53, 55, 56]. In antibody diversification
mechanisms in B cells, AID deaminates a non-methylated cytosine to generate a U:G mis-
match that can be processed by UNG [57]. A somewhat analogous scenario has been proposed
for cytosine demethylation in mouse zygotes [55]. Whether, similarly, UNG acts downstream
of AID in PGCs is presently unclear. However, it is possible that UNG is involved through an
AID-independent pathway.
ATM is a major component of the DNA damage response, and it has recently been impli-
cated in the establishment of DNA methylation patterns during spermatogenesis, as global
DNA methylation was reduced in ATM-deficient testis [58]. Based on this, we expected a
hypomethylated pattern in ATM-deficient sperm. However, Iγ3 was hypermethylated while
Iγ2b was unaffected. This suggests that ATM-mediated demethylation of Iγ3 implicates differ-
ent, yet unknown mechanisms. In contrast, methylation patterns of Iγ3 and Iγ2b promoters
did not significantly change in p53-deficient sperm. p53 has been shown to down-regulate the
de novo DNMT3A and DNMT3B methyl-transferases and up-regulate TET1 and TET2 in
naïve ESCs, whereas in differentiated cells, p53 became a repressor of Tet1 and Tet2 genes
[59]. None of these modes of regulation seems to target Iγ3 and Iγ2b promoters although an
effect of p53 at a discrete developmental stage can not be excluded.
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Overall, the methylation pattern of Iγ3, but not of Iγ2b promoter, was perturbed in AID,
UNG or ATM-deficient sperm. This suggests that different pathways somehow contribute to
the setting of the methylation patterns of these promoters. Whether these pathways act at the
same developmental stage and whether they interact with each other and/or with other path-
ways is presently unknown. In contrast, none of the pathways studied was significantly
required for the maintenance of the unmethylated state of Iγ3 and Iγ2b promoters in resting
splenic B cells. Thus, once the demethylation mark has been set up, the involved pathways
seem dispensable for the maintenance of the mark at subsequent B cell developmental stages.
Though still debatable, accumulated evidence supports the notion that at least some of the
epigenetic features that underlie tissue-specific expression are somehow stamped at earlier
developmental stages, prior to the specification of the relevant lineage [39, 60, 61]. For
instance, asynchronous replication, set up early during development, was suggested to epige-
netically mark antigen receptor loci for mono-allelic recombination at the right developmental
stage [62, 63]. Some, but not all, B cell-specific enhancers are primed in hematopoietic stem
cells (e.g. [64–67]). Other tissue-specific genes are epigenetically marked in ESCs [68, 69].
Regarding DNA methylation specifically, different tissue-specific enhancers, but not promot-
ers, displayed a subset of hypomethylated CpGs in ESCs [25, 70].
What could be the functional significance of the overall hypomethylated pattern of Iγ3 pro-
moter? Splenic marginal zone B cells represent a special population of the adaptive immune
system. These “innate-like” lymphocytes [71] play an important role in rapid protective
responses against blood-borne antigens. They are in a state of active readiness and switch to
IgG3 preferentially in response to T-cell-independent antigens [71]. We speculate that the
early set-up of the hypomethylated pattern of Iγ3 may be part of an epigenetic programme that
predisposes this promoter for fast activation in marginal zone B cells.
In conclusion, methylation patterns of IgH constant locus elements are essentially tran-
scription-independent. The mature B cell-specific Iγ3 promoter is hypomethylated early dur-
ing ontogeny. Iγ3 and Iγ2b promoters recruit different demethylation pathways that are
dispensable for the maintenance of the demethylation mark once established in the B cell line-
age. Further investigations are required to unravel the multiple facets of DNA methylation reg-
ulation at the IgH locus during development and to elucidate the mechanisms that control the
process.
Materials and methods
Ethics statement
The experiments on mice were carried out according to the CNRS Ethical guidelines and were
approved by the Regional Ethical Committee (Accreditation N˚ E31555005).
ES cells, mice
ESCs (CK35 line, of 129Sv background) were provided by Chantal Cress (Institut Pasteur,
Paris, France). The WT and homozygous Rag2-/-, ZILCR, 5’hs1RIΔ/Δ were of 129Sv genetic
background. AID-/-, ATM-/-, UNG-/-, and p53-/- mutant mice were enriched in 129Sv genetic
background through at least 8 back-crosses, and both their chromosomes 12 (harbouring the
IgH locus) were derived from 129Sv. All the mice used were 6–8 week-old. ATM-deficient
mice were purchased from Jackson labs and p53-deficient mice were from the European
Mutant Mouse Archives, Orle´ans, France. AID-deficient mice were provided by T. Honjo,
through C-A. Reynaud and J-C. Weill. UNG-deficient mice were provided by T. Lindahl,
through C. Rada and the late M.S. Neuberger.
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Cell purification
Single cell suspensions from the bone marrows or spleens were obtained by standard tech-
niques. Rag2-deficient pro-B cells (from the bone marrow of Rag2-/- mice) and WT fetal liver
B cells (at day 14 post-coitum) were positively sorted by using B220- and CD19-magnetic
microbeads and MS columns (Miltenyi). Splenic B cells were negatively sorted by using
CD43-magnetic microbeads and LS columns (Miltenyi). Splenic CD4+ cells were sorted as
B220-IgM-CD4+ population. ESCs cells were serum-grown in the presence of LIF (106 units/
ml) throughout: first on mitomycin-treated feeder cells for 2 days, trypsinized and amplified
for additional 2 days without feeders. After trypsinization, the cells were plated on gelatinized
dishes for 2 hours, and the ESC-enriched supernatant carefully pipetted off and plated again
for additional 2 hours in order to get rid of contaminating feeders. Sperm was collected from
the cauda epididymis of adult males by the “swim-up” method [72].
Induction of GL transcription
To induce GL transcription, negatively sorted CD43- splenic B cells were cultured for 2 days, at
a density of 5 x 105 cells per ml in the presence of LPS (25 μg/ml) + anti-IgD-dextran (3 ng/ml)
(hereafter LPS stimulation), LPS (25 μg/ml) + anti-IgD-dextran (3 ng/ml) + IL4 (25 ng/ml) (IL4
stimulation), LPS (25 μg/ml) + anti-IgD-dextran (3 ng/ml) + IFNγ (20 ng/ml) (IFNγ stimula-
tion) or LPS (25 μg/ml) + anti-IgD-dextran (3 ng/ml) + IL4 (10 ng/ml) + IL5 (5 ng/ml) + BLyS
(5 ng/ml) + TGFβ (2 ng/ml) (TGFβ stimulation).
Genomic DNAs
Genomic DNAs were purified from the following sources: sorted resting splenic B cells from
WT, 5’hs1RIΔ/Δ, AID-/-, UNG-/-, ATM-/-, and p53-/- mutant mice; from WT, ZILCR, AID-/-
splenic B cells at day 2 post-stimulation; from WT ESCs, resting splenic CD4+ T cells, and fetal
liver B220+ cells; from pro-B cells or from the tail of Rag2-/- mice; from mature sperm of WT,
UNG-/-, AID-/-, ATM-/-, and p53-/- mutant mice.
DNA methylation analyses
Purified genomic DNAs were assayed by sodium bisulphite sequencing by using a bisulphite
conversion kit (Diagenode). Modified templates were amplified by PCR using converted prim-
ers listed in S1 Table. Converted primers were designed by using the public MethPrimer soft-
ware. PCR products were separated by agarose gel electrophoresis, purified using QIAquick
gel extraction kit (Qiagen), and cloned into pCR2.1-TOPO vector (Invitrogen). Transformed
bacteria were plated immediately after transformation without pre-culture, and randomly
picked clones were sequenced (Eurofins Genomics). Sequence analysis showed 99%-100%
bisulphite modification efficiency.
Antibodies and cytokines
Allophycocyanin (APC)-conjugated anti-B220, fluorescein isothiocyanate (FITC)-conjugated
anti-IgG1, Phycoerythrin (PE)-conjugated anti-IgG2b, PE-conjugated anti-IgG2a, and PE-
conjugated anti-CD4 antibodies were purchased from BioLegend. FITC-conjugated anti-IgG3
and FITC-conjugated anti-IgA were from BD-Pharmingen. LPS was purchased from Sigma,
anti-IgD-dextran from Fina Biosolutions, TGFβ, B-LyS, IFNγ and IL5 from R&D, and IL4
from eBiosciences.
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Flow cytometry analyses (FACS)
At day 4 post-stimulation, B cells were washed and stained with anti-B220-APC and either anti-
IgG3-FITC, anti-IgG2b-PE, anti-IgG1-FITC, anti-IgG2a or anti-IgA-FITC. Activated B cells
from AID-deficient mice (unable to initiate CSR) were included throughout as negative con-
trols. Data were obtained on 5 x 105 viable cells by using a BD FACSCalibur flow cytometer.
Reverse transcription-quantitative PCR (RT-qPCR)
Total RNAs were prepared from B cells at day 2 post-stimulation, reverse transcribed (Invitro-
gen) and subjected to qPCR using Sso Fast Eva Green (BioRad). Actin transcripts were used
for normalization. The primers used have been described [13].
Statistical analysis
Results are expressed as mean ± SD (GraphPad Prism) and overall differences between values
from day 0 and day 2 post-stimulation were evaluated by paired t-test, and from WT and AID-,
UNG-, ATM- and p53-deficient sperm by unpaired t-test. The difference between means is sig-
nificant if p value< 0.05 (�), very significant if p value< 0.01 (��), and extremely significant if
p value< 0.001 (���).
Supporting information
S1 Fig. Induction of GL transcription and class switching. CD43− sorted splenic B cells from
WT mice were induced to switch to IgG3 and IgG2b (LPS stimulation), to IgG2a (IFNγ stimu-
lation), to IgG1 and IgE (IL4 stimulation) or to Ig2b and IgA (TGFβ stimulation). Total RNAs
were prepared at day 0 and day 2 post-stimulation, reverse transcribed and the indicated
spliced GL transcript levels were quantified by RT-qPCR (n�4). ��� p<0.001; �� p<0.01; �
p<0.05. The scheme on the right shows the relative localization of the primers used to amplify
the spliced forms of GL transcripts. GL transcripts initiate at multiple transcription start sites
(for convenience, only one is indicated by the arrow), run across the S sequences and undergo
polyadenylation downstream of the constant (Cx) exons. Splicing enables fusion of I exon
to the C exons and excision of the intervening sequences. Note that γ2a and α primary GL
transcripts have three splice donor sites, the primers used amplify only one form of spliced
transcript. At day 4 post-stimulation, the cells were stained with the indicated antibodies. Acti-
vated AID-deficient B cells are unable to switch and are included as negative controls. Repre-
sentative plots are shown (n�3). There are currently no reliable antibodies to stain surface IgE,
therefore, we did not perform the corresponding FACS.
(TIF)
S2 Fig. Localization of the sequenced CpGs with regard to known transcription factors
binding sites and relative distances between them. The schemes represent the relative posi-
tion of the mapped CpGs at the promoters and upstream regions, I exons, Cγ3, Cγ1, Cγ2b and
Cα constant exons, and Cγ1-Iγ2b intergenic region. While all promoters CpGs are conserved
between 129Sv and C57BL/6 mouse strains, there are differences between few CpGs outside
the promoters. Orange circles indicate discrete CpGs for which we could not design reliable
converted primers, or that are not conserved between 129Sv and C57/Black6 mouse lines, or
that we did not target in this study. For the sake of clarity, not all these CpGs are shown.
Where it applies, their number is indicated below (e.g. there are 12 CpGs between CH3 and
mb1 exons of Cγ3 gene, hence x12). The numbers in red indicate the length of the sequence
(in bp) encompassing the indicated CpGs, bordered by the first and the last CpGs (e.g. the 8
CpGs at Iγ1 exon are contained within 384 bp, which is also the distance between the first and
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the last CpGs). The numbers in blue indicate the distance (in bp) between the sequenced
CpGs. I promoters, 3’γ1E and 5’γ2bE are magnified in the upper schemes to indicate the posi-
tion of the CpGs relative to transcription factor (TF) binding sites and TSSs (indicated by a
single arrow). The data on TFs as well as on the multiple TSSs are compiled from [21, 22, 33],
from supplementary references [1–20] in S1 Text, and from bioinformatics analyses using the
JASPAR database.
(TIF)
S3 Fig. Percentages of methylated CpGs at GL promoter/exon regions in resting and acti-
vated splenic B cells. Genomic DNAs were purified from resting (d0) and activated (d2)
splenic B cells, and assayed by bisulphite sequencing. The indicated d2 correspond to (A) LPS
stimulation, (B) IL4 stimulation, (C) IFNγ stimulation, (D) TGFβ stimulation. For the sake of
simplicity, only the most proximal hypermethylated CpGs upstream of I promoters are shown
in the upper schemes (see Fig 1).
(TIF)
S4 Fig. Iγ1 and Iα GL promoters are hypermethylated in the sperm of WT adult males.
Bisulphite sequencing maps of the CpGs at Iγ1 and Iα GL promoters are shown (compare to
Fig 4A and Fig 5A).
(TIF)
S5 Fig. Methylation pattern of Iγ3 and Iγ2b promoters during ontogeny. The scheme reca-
pitulates the methylation states of Iγ3 (red) and Iγ2b (yellow) promoters at various stages of
development. For convenience, among non-B cells, only sperm and ESCs are shown.
(TIF)
S1 Text. References associated with S2 Fig.
(DOCX)
S1 Table. PCR oligonucleotides used in this study.
(PDF)
S2 Table. Localization of the converted primers within the sequence of the mouse IgH
locus (129S1 strain. GenBank accession number: AJ851868.3).
(PDF)
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